Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer

BACKGROUND: Treatment outcomes of advanced non-small cell lung cancer (NSCLC) have substantially improved with immune checkpoint inhibitors (ICI), although only approximately 19% of patients respond to immunotherapy alone, increasing to 58% with the addition of chemotherapy. The gut microbiome has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyein, Andrew F., Bari, Shahla, Hogue, Stephanie, Zhao, Yayi, Maller, Bradley, Sha, Sybil, Gomez, Maria F., Rollison, Dana E., Robinson, Lary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787935/
https://www.ncbi.nlm.nih.gov/pubmed/35073876
http://dx.doi.org/10.1186/s12885-022-09210-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787935/
https://www.ncbi.nlm.nih.gov/pubmed/35073876
http://dx.doi.org/10.1186/s12885-022-09210-2

Ejemplares similares